Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03316118 · ClinicalTrials.gov registry record · Phase 4
US Guided GNB vs Saline Injection for TKA
A Phase 4 study, sponsored by Northwestern University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 2
- Enrollment target
NCT03316118 is a Phase 4 study that was terminated before completion, run by Northwestern University. The registered enrollment target is 2 participants.
The verdict
NCT03316118, a Phase 4 study, was terminated before completion, sponsored by Northwestern University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 2 participants
- Enrollment target
Study Summary
Do ultrasound-guided genicular nerve blocks with 0.5% bupivacaine provide improved knee analgesia for patients recovering from total knee replacement surgery compared to saline injection? Hypotheses: The investigators hypothesize that the combination of ultrasound-guided adductor canal block (ACB) and genicular nerve block will achieve lower opioid consumption and therefore lead to decreased systemic side effects and improved overall satisfaction compared to ultrasound-guided saline injection for patients undergoing minimally invasive elective total knee arthroplasty (TKA).
Interventions
- DRUG saline
- DRUG bupivacaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2017-10-05 |
| Est. Completion | 2021-06-21 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03316118
The ClinicalTrials.gov registry entry for NCT03316118 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which saline is the first listed.
NCT03316118 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03316118 about?
NCT03316118 is a clinical study titled "US Guided GNB vs Saline Injection for TKA". Do ultrasound-guided genicular nerve blocks with 0.5% bupivacaine provide improved knee analgesia for patients recovering from total knee replacement surgery compared to saline injection? Hypotheses: The investigators hypothesize that the combination of ultrasound-guided adductor canal block (ACB)...
What is the current status of trial NCT03316118?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 2 participants. The study started on 2017-10-05. Estimated completion is 2021-06-21.
What interventions are being tested in trial NCT03316118?
The interventions under investigation include: saline (DRUG), bupivacaine (DRUG).
Who is sponsoring clinical trial NCT03316118?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.